Prevalence of Non-Alcoholic Fatty Liver and its Related Factors in Birjand, During Year 2015

Authors Information
Article Notes and Dates
To Cite : Azarkar G, Zeinali T, Sharifzadeh G, Abedi F, Hajihosseini M, et al. Prevalence of Non-Alcoholic Fatty Liver and its Related Factors in Birjand, During Year 2015, Mod Care J. 2016 ;13(4):e58829. doi: 10.5812/modernc.58829.
Copyright: Copyright © 2016, Modern Care Journal. .
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Safarpor M, Kohan L, Porkhajeh AH. Comparative study of anthropometric parameters in non-alcoholic fatty liver disease patients and healthy subjects [In Persian]. Q J Sabzevar Univ Med Sci. 2015;22(2):231-25.
  • 2. Dehghan P, Miwechi M, Izadi E, Mohammadi F, Sohrabi MR. Comparison of physical activity and body mass index in patients with and without non-alcoholic fatty liver disease [In Persian]. Commun Health. 2015;1(2):81-8.
  • 3. St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology. 2009;50(1):68-76. doi: 10.1002/hep.22940. [PubMed: 19444870].
  • 4. Alavian S, Ramezani M, Bazzaz A, Azuzabadi Farahani M, Behnava B, Keshvari M. Frequency of fatty liver and some of its risk factors in asymptomatic carriers of HBV attending the Tehran blood transfusion organization hepatitis clinic [In Persian]. Iran J Endocrinol Metab. 2008;10(2):99-106.
  • 5. Nikroo H, Mohammadian M, Nematy M, Sima HR, Attarzadeh Hosseini SR. The effect of diet and exercise onimprovement of quality of life in patients with nonalcoholic steatohepatitis [In Persian]. J Kerman Univ Med Sci. 2015;22(1):61-72.
  • 6. Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(7):1724-45. doi: 10.3748/wjg.v20.i7.1724. [PubMed: 24587651].
  • 7. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63. doi: 10.1111/j.1478-3231.2008.01790.x. [PubMed: 18492015].
  • 8. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013;13(5). e9248. doi: 10.5812/hepatmon.9248. [PubMed: 23922564].
  • 9. Kirovski G, Schacherer D, Wobser H, Huber H, Niessen C, Beer C, et al. Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp Med. 2010;3(3):202-10. doi: 10.1055/s-0029-1246560. [PubMed: 20827318].
  • 10. Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. [PubMed: 19476560].
  • 11. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95. doi: 10.1002/hep.20466. [PubMed: 15565570].
  • 12. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44-52. doi: 10.1002/hep.20734. [PubMed: 15895401].
  • 13. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745-52. doi: 10.1097/00004836-200609000-00016. [PubMed: 16940890].
  • 14. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13(47):6419-24. doi: 10.3748/wjg.v13.i47.6419. [PubMed: 18081233].
  • 15. Li H, Wang YJ, Tan K, Zeng L, Liu L, Liu FJ, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009;8(4):377-82. [PubMed: 19666406].
  • 16. De Lusong MA, Labio E, Daez L, Gloria V. Non-alcoholic fatty liver disease in the Philippines: comparable with other nations?. World J Gastroenterol. 2008;14(6):913-7. doi: 10.3748/wjg.14.913. [PubMed: 18240349].
  • 17. Rocha R, Cotrim HP, Bitencourt AG, Barbosa DB, Santos AS, Almeida Ade M, et al. Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. World J Gastroenterol. 2009;15(4):473-7. doi: 10.3748/wjg.15.473. [PubMed: 19152453].
  • 18. Adibi A, Kelishadie R, Beihaghi A, Salehi HR, Talaei M12. Prevalence of sonographic fatty liver in overweight and obese children; a cross sectional study in Isfahan [In Persian]. J Shaheed Sadoughi Univ Med Sci. 2009;17(4):270-80.
  • 19. Johnson NA, Keating SE, George J. Exercise and the liver: implications for therapy in fatty liver disorders. Semin Liver Dis. 2012;32(1):65-79. doi: 10.1055/s-0032-1306427. [PubMed: 22418889].
  • 20. Nseir W, Hellou E, Assy N. Role of diet and lifestyle changes in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(28):9338-44. doi: 10.3748/wjg.v20.i28.9338. [PubMed: 25071328].
  • 21. Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, et al. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol. 2015;6(1):44-51. doi: 10.1136/flgastro-2014-100432. [PubMed: 25580206].
  • 22. Moghimi-Dehkordi B, Safaee A, Vahedi M, Pourhoseingholi MA, Pourhoseingholi A, Zali MR. The prevalence of obesity and its associated demographic factors in Tehran, Iran [In Persian]. Journal of Health & Development. 2012;1(1):22-30.
  • 23. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9). e36452. doi: 10.5812/hepatmon.36452. [PubMed: 27822260].
  • 24. Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, et al. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. Iran J Public Health. 2014;43(9):1275-83. [PubMed: 26175982].
  • 25. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol. 2007;47(2):239-44. doi: 10.1016/j.jhep.2007.02.007. [PubMed: 17400323].
  • 26. Savadkoohi F, Hosseini Tabatabaei MT, Shahabi Nezhad S. The frequency of fatty liver in sonography of patients without liver diseases background and its correlation with blood cholesterol and triglyceride [In Persian]. Tabib-e-Shargh J Zahedan Univ Med Sci. 2003;4(3):177-83.
  • 27. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844-50. [PubMed: 11473047].
  • 28. Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6(3):161-3. [PubMed: 17786142].
  • 29. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol. 2005;20(2):229-33. doi: 10.1111/j.1440-1746.2004.03511.x. [PubMed: 15683425].
  • 30. Sohrabpour A, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S, Pourshams A. Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. Middle East J Dig Dis. 2010;2(1):14-9. [PubMed: 25197507].
  • 31. Kolahi AA, Pakdaman R, Mivehchi M, Dehghan P. Comparison of nutritional behaviors and body mass index in patients with and without non-alcoholic fatty liver diseases. Commun Health. 2015;2(1):9-16.
  • 32. Joven J, Espinel E, Rull A, Beltran-Debon R, Aragones G, Rodriguez-Gallego E, et al. Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis. J Clin Virol. 2011;51(3):199-201. doi: 10.1016/j.jcv.2011.04.003. [PubMed: 21555238].
  • 33. Shiasi Arani K, Haghshenas M, Talari HR, Akbari H, Hami K. Prevalence of fatty liver disease in obese children and adolescents who referred to pediatric clinic of Kashan University of Medical Sciences, Iran (2012-2013) [In Persian]. J Babol Univ Med Sci. 2013;15(5):77-83.
  • 34. Altlparmak E, Koklu S, Yalinkilic M, Yuksel O, Cicek B, Kayacetin E, et al. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol. 2005;11(20):3056-9. [PubMed: 15918189].
  • 35. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. doi: 10.1186/1471-230X-6-33. [PubMed: 17081293].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By: